SGMC Health to Launch Family Medicine Residency Program
February 11, 2025 - 23:52
SGMC Health is set to enhance its graduate medical education (GME) offerings with the introduction of a Family Medicine residency program, scheduled to commence in July 2026. This initiative aims to address the growing demand for primary care physicians in the region, ensuring that local communities have access to quality healthcare services.
The Family Medicine residency will provide comprehensive training for new physicians, equipping them with the skills necessary to address a wide range of health issues across diverse patient populations. The program is designed to foster a deep understanding of family dynamics and preventive care, emphasizing the importance of holistic treatment approaches.
By expanding its training capabilities, SGMC Health is not only investing in the future of healthcare but also contributing to the local economy by creating new educational opportunities. This residency program reflects a commitment to cultivating a robust pipeline of skilled healthcare professionals dedicated to serving the community's needs.
MORE NEWS
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...